RIVANNA
Rivanna Medical, founded in 2010 and based in Charlottesville, VA, is a commercial-stage medical device innovator and manufacturer specializing in world-first imaging-based medical technologies. Their flagship product, Accuro, is an AI-enabled ultrasound guidance system designed to improve the safety, precision, and efficiency of neuraxial anesthesia procedures, significantly increasing first-attempt success rates and reducing complications. The company operates an FDA-registered and ISO 13485:2016 certified manufacturing facility and has secured multiple government contracts and NIH grants totaling tens of millions of dollars. With over 200 hospitals across 5 continents using their technology, Rivanna Medical is positioned as a leader in medical imaging innovation, focusing on cost-effective, radiation-free solutions that enhance patient outcomes and clinical workflow.
RIVANNA
Rivanna Medical, founded in 2010 and based in Charlottesville, VA, is a commercial-stage medical device innovator and manufacturer specializing in world-first imaging-based medical technologies. Their flagship product, Accuro, is an AI-enabled ultrasound guidance system designed to improve the safety, precision, and efficiency of neuraxial anesthesia procedures, significantly increasing first-attempt success rates and reducing complications. The company operates an FDA-registered and ISO 13485:2016 certified manufacturing facility and has secured multiple government contracts and NIH grants totaling tens of millions of dollars. With over 200 hospitals across 5 continents using their technology, Rivanna Medical is positioned as a leader in medical imaging innovation, focusing on cost-effective, radiation-free solutions that enhance patient outcomes and clinical workflow.
